J. Goldman & CO LP Apellis Pharmaceuticals, Inc. Put Options Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $1.04 Million - $1.26 Million	13,500 New	13,500 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $2.42 Million - $3.76 Million	54,000 New	54,000 $3.69 Million
Q2 2021 Aug 16, 2021	SELL	$40.9 - $64.9 $552,150 - $876,150	-13,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $550,800 - $774,765	13,500 New	13,500 $579,000

308

115M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.